Detail akcie Tactile Systms T Rg online

Business Summary: Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Tactile Systems Technology Inc revenues increased 9% to $225.9M. Net income increased 17% to $8.5M. Revenues reflect Airway clearance products segment increase of 47% to $37M, Lymphedema products segment increase of 4% to $188.9M. Net income benefited from Research and development - Balancing val decrease of 13% to $5.8M (expense), Stock-based Compensation in S& M decrease of 31% to $1.3M (expense).